Cancer Genetics and Epigenetics 2024, Vol.12, No.4, 166-181 http://medscipublisher.com/index.php/cge 175 7.3 Case studies and clinical trials Several case studies and clinical trials have demonstrated the benefits of personalized medicine approaches in breast cancer. One notable example is the study conducted by Kawaguchi-Sakita et al., which evaluated the impact of genetic counseling on patients with hereditary breast cancer. The study found that genetic counseling significantly improved patients' understanding and management of their condition, as measured by the Genetic Counseling Outcome Scale (GCOS-24) (Kawaguchi et al., 2023). This study highlights the importance of genetic counseling in empowering patients and facilitating informed decision-making. Another example is the Making Genetic Testing Accessible (MAGENTA) trial, which assessed the impact of omitting pretest and posttest genetic counseling on patient distress during remote genetic testing. The trial found that omitting counseling did not increase distress, suggesting that alternative models of genetic risk assessment, such as remote testing, can be effective and may help overcome barriers to access (Swisher et al., 2023). This finding is particularly relevant in the context of the ongoing shortage of genetic counselors. Additionally, a randomized controlled trial conducted in Mexico City compared the effectiveness of a pretest educational video to in-person genetic counseling. The study found that the educational video was non-inferior to in-person counseling in terms of genetic testing acceptance, knowledge improvement, and anxiety reduction (Guerra et al., 2023). These results support the use of innovative approaches to genetic counseling, particularly in resource-limited settings. In conclusion, genetic testing and personalized medicine are transforming the landscape of breast cancer treatment. While there are challenges in the implementation of genetic counseling and testing, ongoing research and innovative approaches are helping to address these issues and improve patient outcomes. The integration of genetic information into clinical practice enables more targeted and effective therapies, ultimately enhancing the quality of care for breast cancer patients. 8 Ethical, Legal, and Social Implications of Genetic Research in Breast Cancer 8.1 Ethical considerations in genetic testing Genetic testing for breast cancer susceptibility, particularly involving BRCA1 and BRCA2 mutations, presents numerous ethical dilemmas. One significant issue is the "duty to warn" relatives about inherited cancer risks. This raises questions about the balance between patient confidentiality and the potential benefits of informing family members who might also be at risk (Offit and Thom, 2007). Additionally, the appropriateness of testing children and embryos for genetic predispositions is contentious, as it involves making decisions that could impact an individual's future autonomy and psychological well-being (Surbone, 2001; Offit and Thom, 2007). The psychological impact of genetic knowledge is another ethical concern. Some women may experience significant anxiety and stress upon learning their genetic risk, which can affect their quality of life and decision-making processes regarding preventive measures such as prophylactic surgeries (Surbone, 2001). Conversely, others may find empowerment in this knowledge, using it to make informed decisions about their health and lifestyle (Surbone, 2001). The ethical challenge lies in ensuring that individuals are fully informed and supported throughout the testing process to make decisions that align with their values and preferences. 8.2 Legal frameworks and genetic information The legal landscape surrounding genetic testing for breast cancer is complex and varies by jurisdiction. One of the primary legal concerns is genetic discrimination, where individuals may face unfair treatment based on their genetic information. This can occur in various contexts, including employment and insurance. For instance, individuals with a known genetic predisposition to breast cancer might be denied health insurance coverage or charged higher premiums, which raises significant ethical and legal questions about equity and justice (Ee, 1998; Offit and Thom, 2007). Privacy issues are also paramount in the context of genetic testing. The handling and sharing of genetic information must be carefully managed to protect individuals' privacy. The use of electronic health records and
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==